BioNTech SE BNTX
NASDAQ BNTX
$98.45 -0.12 (-0.12%)
As of: Sep 30, 2026 · 3:59 PM EDT

BioNTech SE (BNTX) Operating Margin (2018 - 2026)

Updated

BioNTech SE (BNTX) posted Operating Margin of -897.82% for Q2 2026, down 705.68 percentage points from -192.14% a year earlier and down 324.16 percentage points from the prior quarter.

Analysis

BioNTech SE (BNTX) Operating Margin (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Margin at BioNTech SE was -75.20%, down 44.53 percentage points year-over-year; for FY2025, it came in at -48.95%, down 1.18 percentage points from FY2024.

  • Annual Operating Margin has declined for four consecutive years, with a five-year change of -31.87 percentage points (FY2020 to FY2025).
  • In prior years, BioNTech SE's Operating Margin was -47.77% in FY2024 (-65.85 pp), 18.08% in FY2023 (-54.96 pp), 73.03% in FY2022 (-7.51 pp) and 80.54% in FY2021 (+97.62 pp).
  • The Q2 2026 figure stands as the lowest quarterly Operating Margin in data going back to Q3 2018.
  • On a year-over-year basis, Operating Margin has declined in each of the last four quarters, with an average year-over-year change of -66.60 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Operating Margin in the past five years was Q2 2025, with a gain of 558.60 percentage points; the weakest was Q2 2026, with a drop of 705.68 percentage points.
  • According to Business Quant data, Operating Margin for the three prior quarters was -573.67% (Q1 2026), -35.57% (Q4 2025) and -3.09% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 BioNTech SE 24.93 Bn -34.44 Bn 10.00 Mn -897.82%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -897.82%
Mar 31, 2026 -573.67%
Dec 31, 2025 -35.57%
Sep 30, 2025 -3.09%
Jun 30, 2025 -192.14%
Mar 31, 2025 -292.18%
Dec 31, 2024 12.49%
Sep 30, 2024 0.84%
Jun 30, 2024 -750.74%
Mar 31, 2024 -270.36%
Dec 31, 2023 35.58%
Sep 30, 2023 8.16%
Jun 30, 2023 -335.90%
Mar 31, 2023 51.25%
Dec 31, 2022 76.97%
Sep 30, 2022 68.98%
Jun 30, 2022 69.13%
Mar 31, 2022 74.56%
Dec 31, 2021 84.95%
Sep 30, 2021 77.60%
API Access

BioNTech SE Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=BNTX&period=max&api_key=YOUR_API_KEY